TEST BANK Pharmacology and the Nursing Process 9th Edition Linda Lane Lilley.

Page 15

Chapter 03: Lifespan Considerations

Chapter 03: Lifespan Considerations MULTIPLE CHOICE 1. Drug transfer to the fetus is more likely during the last trimester of pregnancy for which reason? a. Decreased fetal surface area b. Increased placental surface area c. Enhanced blood flow to the fetus d. Increased amount of protein-bound drug in maternal circulation ANS: C

Drug transfer to the fetus is more likely during the last trimester as a result of enhanced blood flow to the fetus. The other options are incorrect. Increased fetal surface area, not decreased, is a factor that affects drug transfer to the fetus. The placenta’s surface area does not increase during this time. Drug transfer is increased because of an increased amount of free drug, not proteinbound drug, in the mother’s circulation. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: General MSC: NCLEX: Health Promotion and Maintenance 2. The nurse is monitoring a patient who is in the 26th week of pregnancy and has developed

gestational diabetes and pneumonia. She is given medications that pose a possible fetal risk, but the potential benefits may warrant the use of the medications in her situation. The nurse recognizes that these medications are in which U.S. Food and Drug Administration pregnancy safety category? a. Category X b. Category B c. Category C d. Category D ANS: D

Pregnancy category D fits the description given. Category B indicates no risk to animal fetus; information for humans is not available. Category C indicates adverse effects reported in animal fetus; information for humans is not available. Category X consists of drugs that should not be used in pregnant women because of reports of fetal abnormalities and positive evidence of fetal risk in humans. DIF: COGNITIVE LEVEL: Understanding (Comprehension) TOP: NURSING PROCESS: Assessment MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control 3. When discussing dosage calculation for pediatric patients with a clinical pharmacist, the nurse

notes that which type of dosage calculation is used most commonly in pediatric calculations? a. West nomogram b. Clark rule c. Height-to-weight ratio d. Milligram per kilogram of body weight formula

14


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Chapter 56: Dermatologic Drugs

18min
pages 305-318

Chapter 55: Nutritional Supplements

4min
pages 300-304

Chapter 54: Anemia Drugs

7min
pages 293-299

Chapter 52: Antiemetic and Antinausea Drugs

13min
pages 282-292

Chapter 51: Bowel Disorder Drugs

8min
pages 275-281

Chapter 48: Immunosuppressant Drugs

18min
pages 259-274

Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs

5min
pages 254-258

Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell

12min
pages 243-253

Chapter 44: Anti-inflammatory and Antigout Drugs

6min
pages 237-242

Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs

5min
pages 232-236

Chapter 42: Antifungal Drugs

6min
pages 227-231

Chapter 41: Antitubercular Drugs

6min
pages 222-226

Chapter 39: Antibiotics Part 2

12min
pages 212-221

Chapter 38: Antibiotics Part 1

8min
pages 205-211

Chapter 37: Respiratory Drugs

7min
pages 199-204

Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants

5min
pages 194-198

Chapter 35: Men’s Health Drugs

4min
pages 189-193

Chapter 34: Women’s Health Drugs

8min
pages 182-188

Chapter 27: Antilipemic Drugs

43min
pages 144-181

Chapter 26: Coagulation Modifier Drugs

7min
pages 138-143

Chapter 25: Antidysrhythmic Drugs

6min
pages 132-137

Chapter 24: Heart Failure Drugs

6min
pages 126-131

Chapter 23: Antianginal Drugs

7min
pages 120-125

Chapter 22: Antihypertensive Drugs

7min
pages 114-119

Chapter 19: Adrenergic-Blocking Drugs

17min
pages 99-113

Chapter 17: Substance Use Disorder

10min
pages 89-98

Chapter 16: Psychotherapeutic Drugs

8min
pages 82-88

Chapter 15: Antiparkinson Drugs

5min
pages 77-81

Chapter 13: Central Nervous System Stimulants and Related Drugs

12min
pages 67-76

Chapter 12: Central Nervous System Depressants and Muscle Relaxants

6min
pages 62-66

Chapter 09: Photo Atlas of Drug Administration

25min
pages 42-61

Chapter 06: Patient Education and Drug Therapy

14min
pages 30-41

Chapter 05: Medication Errors: Preventing and Responding

4min
pages 27-29

Chapter 04: Cultural, Legal, and Ethical Considerations

7min
pages 21-26

Chapter 03: Lifespan Considerations

8min
pages 15-20

Chapter 02: Pharmacologic Principles

8min
pages 9-14

Chapter 01: The Nursing Process and Drug Therapy

5min
pages 5-8
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.